Business Description
Hans Biomed Corp
NAICS : 339112
SIC : 3841
ISIN : KR7042520007
Compare
Compare
Traded in other countries / regions
042520.Korea IPO Date
2009-10-09Description
Hans Biomed Corp manufactures and markets bioengineering products. The company manufactures artificial skin for a skin graft, various bones mainly for dental implants and joints and medical silicone.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.25 | |||||
| Equity-to-Asset | 0.6 | |||||
| Debt-to-Equity | 0.4 | |||||
| Debt-to-EBITDA | -2.72 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.32 | |||||
| Beneish M-Score | -2.79 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3.6 | |||||
| 3-Year EBITDA Growth Rate | -0.2 | |||||
| 3-Year EPS without NRI Growth Rate | -14.7 | |||||
| 3-Year FCF Growth Rate | -16.2 | |||||
| 3-Year Book Growth Rate | -11 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.75 | |||||
| 9-Day RSI | 37.76 | |||||
| 14-Day RSI | 41.23 | |||||
| 6-1 Month Momentum % | -3.63 | |||||
| 12-1 Month Momentum % | -7.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.18 | |||||
| Quick Ratio | 0.53 | |||||
| Cash Ratio | 0.17 | |||||
| Days Inventory | 314.85 | |||||
| Days Sales Outstanding | 52.96 | |||||
| Days Payable | 18.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5 | |||||
| Shareholder Yield % | 11.17 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 59.32 | |||||
| Operating Margin % | -4.34 | |||||
| Net Margin % | -25.15 | |||||
| FCF Margin % | -6.02 | |||||
| ROE % | -34.81 | |||||
| ROA % | -15.78 | |||||
| ROIC % | -2.8 | |||||
| ROC (Joel Greenblatt) % | -23.62 | |||||
| ROCE % | -24.3 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.86 | |||||
| PB Ratio | 2.32 | |||||
| Price-to-Tangible-Book | 2.34 | |||||
| EV-to-EBIT | -12 | |||||
| EV-to-EBITDA | -17.94 | |||||
| EV-to-Revenue | 2.42 | |||||
| EV-to-FCF | -40.24 | |||||
| Price-to-Median-PS-Value | 0.47 | |||||
| Price-to-Net-Current-Asset-Value | 77.21 | |||||
| Earnings Yield (Greenblatt) % | -8.33 | |||||
| FCF Yield % | -2.8 | |||||
| Forward Rate of Return (Yacktman) % | 8.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hans Biomed Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 78,321.151 | ||
| EPS (TTM) (â‚©) | -1837 | ||
| Beta | 1.05 | ||
| Volatility % | 76.98 | ||
| 14-Day RSI | 41.23 | ||
| 14-Day ATR (â‚©) | 447.986379 | ||
| 20-Day SMA (â‚©) | 13287.5 | ||
| 12-1 Month Momentum % | -7.14 | ||
| 52-Week Range (â‚©) | 11050 - 29700 | ||
| Shares Outstanding (Mil) | 12.99 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hans Biomed Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hans Biomed Corp Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hans Biomed Corp Frequently Asked Questions
What is Hans Biomed Corp(XKRX:042520)'s stock price today?
The current price of XKRX:042520 is â‚©12950.00. The 52 week high of XKRX:042520 is â‚©29700.00 and 52 week low is â‚©11050.00.
When is next earnings date of Hans Biomed Corp(XKRX:042520)?
The next earnings date of Hans Biomed Corp(XKRX:042520) is .
Does Hans Biomed Corp(XKRX:042520) pay dividends? If so, how much?
Hans Biomed Corp(XKRX:042520) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers